Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Receivables (2020 - 2025)

Mainz Biomed's Receivables history spans 2 years, with the latest figure at $50815.0 for Q4 2024.

  • For Q4 2024, Receivables rose 31.4% year-over-year to $50815.0; the TTM value through Dec 2024 reached $50815.0, up 31.4%, while the annual FY2024 figure was $50815.0, 31.4% up from the prior year.
  • Receivables for Q4 2024 was $50815.0 at Mainz Biomed, up from $38672.0 in the prior quarter.
  • Across five years, Receivables topped out at $50815.0 in Q4 2024 and bottomed at $38672.0 in Q4 2023.